Yuval Cohen
Net worth: 286 872 $ as of 31/05/2026
Net worth: 286 872 $ as of 31/05/2026
Yuval Cohen was the founder of Celsus Therapeutics Plc, founded in 2005, and held the title of Director & Senior Vice President in 2013.
Dr. Cohen currently holds the positions of Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013, and Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate from Université de Paris 5 René Descartes.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/03/2026 | 36,267 ( 0.2% ) | 286 872 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Executive Officer | 11/04/2014 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Executive Officer | 01/07/2013 |
| Companies | Position | End |
|---|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Founder | 01/12/2013 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Cape Town
University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions